At CRISPR Medicine News we focus on topics related to genetic medicine, gene therapy and genome editing using CRISPR for treatment of human diseases. We strive to bring the best and most interesting interviews and news on everything related to this exciting and rapidly emerging field.

  • 6articles · 30d
  • 11+ hour agolatest article
  • Aug 19, 2026earliest in window
  • 100%with images
  • 287avg words
articles per day
Categories
  • Science & Nature 5
  • Science & Technology 5
  • Health & Wellness 2
  • STEM 2
  • Business & Industrial 1
  • Health 1
  • Medical 1
  • News 1

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

CRISPR Medicine
crisprmedicinenews.com > news > cmn-moderates-panel-discussion-at-csgct-2026-in-vivo-crispr-medicine-from-scientific-promise-to-p

News: CMN Moderates Panel Discussion at CSGCT 2026??? In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale

11+ hour, 26+ min ago   (337+ words) CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CRISPR Medicine News CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CMN founder Jens-Ole…...

CRISPR Medicine
crisprmedicinenews.com > news > uncoverseq-exposes-off-targets-missed-by-established-standards

News: UNCOVERseq Exposes Off-Targets Missed by Established Standards

2+ week, 5+ day ago   (379+ words) An new end-to-end nomination workflow improves the nomination of genomic sites that may be unintentionally edited by CRISPR-Cas, combining high analytical sensitivity with a comparatively manageable list of candidates for confirmation. Tests in cell lines and human HSPCs suggest clinical…...